Robust, Scalable, and Low-Cost
· Process optimization for affinity chromatography, ion exchange chromatography, hydrophobic interaction chromatography, and mixed-mode chromatography
· Process optimization for virus inactivation/removal
· Process development and optimization for depth filtration, ultrafiltration/diafiltration, and other filtration processes
· Purification process technology transfer and scale-up
· High efficiency： Process development can be completed within 2-3 months
· High quality： Satisfied impurity level
· Diversity： Diversified material screening platforms
· Satisfied yield： The average yield of monoclonal antibodies exceeds 70%
· 360°scope of services：Our services cover a wide variety of protein drugs, including monoclonal antibodies, bispecific antibodies, recombinant biotherapeutics, fusion proteins, etc.
· More than 10 years of experience in downstream purification development
